Items where Author is "Mack, Frederic"

Article

Kebir, Sied and Schaub, Christina and Junold, Nina and Hattingen, Elke and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Galldiks, Norbert and Weller, Johannes and Mack, Frederic and Tzaridis, Theophilos and Baehr, Oliver and Seidel, Clemens and Schlegel, Uwe and Schmidt-Graf, Friederike and Rohde, Veit and Borchers, Christian and Tabatabai, Ghazaleh and Haenel, Mathias and Sabel, Michael and Gerlach, Ruediger and Krex, Dietmar and Belka, Claus and Vatter, Hartmut and Proescholdt, Martin and Glas, Martin and Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. JOURNAL OF NEURO-ONCOLOGY, 144 (3). pp. 501-509. ISSN 0167-594X, 1573-7373

Weller, Johannes and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Brehmer, Stefanie and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Kebir, Sied and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. LANCET ONCOLOGY, 20 (10). pp. 1444-1453. ISSN 1470-2045, 1474-5488

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortmann, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Kowalski, Thomas and Ringel, Florian and Schmidt-Graf, Friederike and Suchorska, Bogdana and Brehmer, Stefanie and Weyerbrock, Astrid and Renovanz, Miriam and Bullinger, Lars and Galldiks, Norbert and Vajkoczy, Peter and Misch, Martin and Vatter, Hartmut and Stuplich, Moritz and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Schaub, Christina and Stummer, Walter and Tonn, Joerg-Christian and Simon, Matthias and Keil, Vera C. and Nelles, Michael and Urbach, Horst and Coenen, Martin and Wick, Wolfgang and Weller, Michael and Fimmers, Rolf and Schmid, Matthias and Hattingen, Elke and Pietsch, Torsten and Coch, Christoph and Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. LANCET, 393 (10172). pp. 678-688. ISSN 0140-6736, 1474-547X

Schaefer, Niklas and Proescholdt, Martin and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Grauer, Oliver and Goldbrunner, Roland and Friedrich, Franziska and Rohde, veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Grau, Stefan and Haenel, Mathias and Schnell, Oliver and Krex, Dietmar and Vajkoczy, Peter and Tabatabai, Ghazaleh and Mack, Frederic and Schaub, Christina and Tzaridis, Theophilos and Niessen, Michael and Kebir, Sied and Leutgeb, Barbara and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin and Herrlinger, Ulrich (2018) Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. NEURO-ONCOLOGY, 20 (7). pp. 975-985. ISSN 1522-8517, 1523-5866

Schaub, Christina and Kebir, Sied and Junold, Nina and Hattingen, Elke and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Niessen, Michael and Mack, Frederic and Stuplich, Moritz and Tzaridis, Theophilos and Baehr, Oliver and Kortmann, Rolf-Dieter and Schlegel, Uwe and Schmidt-Graf, Friederike and Rohde, Veit and Braun, Christian and Haenel, Mathias and Sabel, Michael and Gerlach, Ruediger and Krex, Dietmar and Belka, Claus and Vatter, Hartmut and Proescholdt, Martin and Herrlinger, Ulrich and Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 144 (8). pp. 1581-1589. ISSN 0171-5216, 1432-1335

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Maciaczyk, Jaroslaw and Grau, Stefan and Schnell, Oliver and Haenel, Mathias and Krex, Dietmar and Vajkoczy, Peter and Gerlach, Ruediger and Kortmann, Rolf-Dieter and Mehdorn, Maximilian and Tuettenberg, Jochen and Mayer-Steinacker, Regine and Fietkau, Rainer and Brehmer, Stefanie and Mack, Frederic and Stuplich, Moritz and Kebir, Sied and Kohnen, Ralf and Dunkl, Elmar and Leutgeb, Barbara and Proescholdt, Martin and Pietsch, Torsten and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. JOURNAL OF CLINICAL ONCOLOGY, 34 (14). 1611-U134. ISSN 0732-183X, 1527-7755

Other

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.